CBRE Group reports Q1 2026 results on May 21 with the stock deep in the red and options traders turning increasingly cautious, though short sellers are absent from the pressure.
Options positioning captures the pre-earnings mood. The put/call ratio has climbed to 0.67, roughly 1.6 standard deviations above its 20-day average of 0.55 — the highest defensive tilt since a brief spike in early April. That demand for downside protection has arrived alongside a rough run for the stock, which has lost 11% on the week and over 11% on the month to close at $129.95. The 14-day RSI sits at a deeply oversold 29.9, a level rarely seen in the stock's recent history. The peer group moved in the same direction: JLL fell 12.6% on the week, CWK dropped 12.3%, and NMRK lost 14.1%, suggesting a sector-wide repricing rather than a CBRE-specific concern.
Short interest, however, tells a far less charged story. At just 1.2% of the free float, short positioning is minimal and barely moving — up less than 1% on the week. The cost to borrow is negligible at 0.43%, and borrow availability remains ample, with no sign of squeeze pressure in the lending market. The ORTEX short score of 28.7 reflects the same picture: bears are not building into this name ahead of the print.
The disconnect between the price action and the short book sharpens the debate between bulls and bears. Analysts are clearly in the bull camp: the consensus target of roughly $178 implies over 37% upside from current levels, and recent target revisions from Barclays and Evercore ISI after the prior quarter's results both went higher. Bulls point to CBRE's growing mix of contractual, fee-based revenues and the long-term institutionalisation of commercial real estate as structural tailwinds with margin expansion potential. Bears counter that the stock, even after the selloff, was trading at 18–21x forward earnings before the recent decline — elevated for a business exposed to transaction volumes and capital markets activity, both of which are vulnerable to a slowing macro. The P/E has compressed nearly 3.3 points over the past 30 days, and EV/EBITDA has eased to around 11.8x, tracking the price lower. At $130, CBRE trades materially below where it was when most of the current analyst targets were set, raising the question of whether the Street will reset expectations.
The May 21 print will test whether CBRE's resilient, fee-driven revenue lines held up through a volatile quarter — and whether management's margin narrative can hold against a backdrop that has clearly spooked the broader real estate services sector.
See the live data behind this article on ORTEX.
Open CBRE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.